openPR Logo
Press release

Rise in Incidence of Bone-Degenerative Diseases Drives the Growth of OTC Orthopedic Braces Market

05-12-2017 04:12 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Rise in Incidence of Bone-Degenerative Diseases Drives

Orthopedic braces are devices which are used to support and control the joints of the body. The braces can be used on the ankle, knee, hip, back, neck, elbow, fingers, and wrist. Orthopedic braces are used to control the position of limbs and initiate specific movement or motion in the body. Also, the braces can be compensated for weak muscles and to correct structural deformities. Orthopedic braces are used extensively for diagnosis of cerebral palsy, spina bifida, spinal cord injury, scoliosis, and to deal with after stroke effects. Braces are also used after surgeries on knee joints in order to keep the joints immobile and control motion until the joints recover. Many people use braces for extra support to prevent injuries to joints. Athletes such as football and rugby players’ particularly use braces to prevent injuries. The sophisticated designs, cost effectiveness, and easy availability are driving the growth of the OTC orthopedic braces market. Custom braces and relevant designs can increase the cost of braces which may restrain the OTC orthopedic braces market growth rate during the forecast period.

Browse through OTC Orthopedic Braces Market report to know what factors will shape the market by 2024: http://www.transparencymarketresearch.com/otc-orthopedic-braces-market.html

Orthotics is an example which is more than a shoe inserts. Orthotics manufacture and design orthoses which modifies the structure and function of the skeletal and neuromuscular system of the body. Demand for orthopedic braces has increased due to increase in the geriatric population, obesity, rising public participation in sports, orthopedic injuries among younger population, and rise in incidence of bone -degenerative diseases, all of which are driving growth in the OTC orthopedic braces market. According to the American Journal of Orthopedics, August 2016, osteoarthritis is a leading cause of disability among middle-aged and older adults, affecting nearly 27 million Americans. Increase in aging of the baby boomer population and rising obesity rates are estimated to increase osteoarthritis by 40% by 2025. Moreover, noninvasive nature of treatment using orthopedic braces and supports, reduced reimbursements offered during orthopedic surgery in developed regions such as North America and Europe are expected to propel the growth opportunities for sports players representing at a global, national or state level. High patient preference for alternative treatments, supports in prophylactic and rehabilitative use and lack of customization options for OTC orthopedic braces can hamper the growth of the global OTC orthopedic brace market during the forecast period.

The OTC orthopedic braces market has been segmented by product type, indication, end-users, and geography. In terms of product type, the OTC orthopedic braces market is classified into foot & ankle braces, upper extremity braces, knee braces, and spinal orthoses braces. In terms of indication type, the market is classified into injury, arthritis, prophylactic, and others. According to the professor of Boston University School of Medicine, knee osteoarthritis is progressive damage to joint cartilage which leads to weakened muscles, pain and swelling. People who wore knee braces reduced pain by about 40% over 6 weeks. In terms of end users, the OTC orthopedic braces market is classified into orthopedic clinics, hospitals, pharmacies, and others. Geographically, the OTC orthopedic braces market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Geographically North America dominates the global OTC orthopedic braces reagents market due to increase in obesity, increase in sports activity, and rise in aging population. Reduced reimbursement policy for surgeries and low cost of braces is expected to drive the OTC orthopedic braces reagents market in North America. Europe is the second largest market for OTC orthopedic braces reagents as there are favorable government policies regarding healthcare infrastructure and awareness programs. Asia Pacific is expected to grow at a higher rate due to rising population, changing lifestyles, rising interest in sports activity among the population, and increasing per capita expenditure. In addition, economic growth is supporting healthcare infrastructure improvement in developing countries such as Brazil, India, and China. Thus, all these factors collectively support the growth of the OTC orthopedic braces reagents market in Asia Pacific and Latin America.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving OTC Orthopedic Braces Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19220

The major players operating in the global OTC orthopedic braces reagents market include ALCARE Co., Ltd., DJO Finance LLC, DeRoyal Industries Inc., Ossur hf., Breg, Inc., 3M Company, Otto Bock HealthCare, Bauerfeind AG, BSN Medical, medi GmbH & Co. KG, and Thuasne Group.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rise in Incidence of Bone-Degenerative Diseases Drives the Growth of OTC Orthopedic Braces Market here

News-ID: 534810 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current